Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Details : Under the terms of the agreement Aquinnah and Roche will collaborate in research activities up to the selection of an advanced brain penetrant oral small molecule, drug candidate to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative di...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 15, 2022
Reset All
